Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 6887673 Humanized antibodies against human 4-1BB

Patent 6887673 was granted and assigned to Bristol-Myers Squibb on May, 2005 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Bristol-Myers Squibb
Bristol-Myers Squibb
0
Date Filed
July 30, 2003
0
Date of Patent
May 3, 2005
0
Patent Application Number
10630406
0
Patent Citations Received
‌
US Patent 11976125 B cell maturation antigen binding proteins
0
‌
US Patent 11981921 TIL expansion processes using specific cytokine combinations and/or AKTi treatment
0
‌
US Patent 11919957 Methods of treating tumor
0
‌
US Patent 11866688 Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
0
‌
US Patent 11851497 CD137 antibodies and tumor antigen-targeting antibodies and uses thereof
0
‌
US Patent 12024718 Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
0
‌
US Patent 12104172 Processes for generating TIL products enriched for tumor antigen-specific t-cells
0
‌
US Patent 12084518 Trispecific binding proteins and methods of use
0
Patent Inventor Names
Robert S. Mittler
0
Barbara Thorne
0
Diane L. Hollenbaugh
0
Jill Rillema
0
Maria Jure Kunkel
0
Ralph Abraham
0
Subinay Ganguly
0
Walter W. Shuford
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
6887673
0
Patent Primary Examiner
‌
Long V. Le
0

Find more entities like US Patent 6887673 Humanized antibodies against human 4-1BB

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo